背景问题:E3联酶-联子配对策略,以优化PROTAC性能.
Luyao Yin1, Pengcheng Shu1, Xiaozhong Peng1,2,3
1State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry & Molecular Biology, Medical Primate Research Center, Neuroscience Center, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, 100005, China.
Protein & cell
|December 10, 2025
概括
针对蛋白质分解的嵌合体 (PROTACs) 提供了一种降解蛋白质的新方法. 选择正确的E3结合酶-结合体对对于PROTAC的有效性至关重要,因为环境决定了最佳策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 蛋白质溶解向嵌合体 (PROTACs) 代表了一种开创性的治疗方式.
- PROTACs使蛋白质的向降解成为可能,包括那些以前被认为是无毒的蛋白质.
- 虽然目标参与是关键的,但E3酶选择在PROTAC疗效中的作用往往被低估.
研究的目的:
- 系统地分析E3结合酶-结合体对PROTAC降解效率和选择性的影响.
- 在 PROTAC 设计中为优化 E3 酶选择提供战略框架.
- 探索新兴的E3链酶和PROTAC技术的新应用.
主要方法:
- 在各种生物环境中对E3联酶-联子对进行比较分析.
- 评估三元复合合作性,细胞类型特异性和组织分布.
- 对E3酶家族 (CRBN,VHL,IAP,DCAF) 的当前文献和新兴数据的综述.
主要成果:
- 没有一个单一的E3酶-干化合物组合是普遍最佳的;有效性取决于上下文.
- 基于CRBN的PROTAC在血液恶性瘤中是有效的,而基于VHL的PROTAC在固体瘤中显示出希望.
- 新兴的E3链酶有潜力克服耐药性并扩大向蛋白质降解的范围.
结论:
- 战略性的E3酶选择对于最大限度地提高PROTAC的疗效和选择性至关重要.
- "上下文决定战略"是优化 PROTAC 设计的核心范式.
- PROTACs具有治疗应用和作为化学淘汰研究工具的巨大潜力.
相关概念视频
Ligand Binding and Linkage
5.4K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.4K
Ligand Binding and Linkage
3.9K
3.9K
Ligand Binding Sites
14.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.8K
Ligand Binding Sites
8.5K
8.5K
EDTA: Chemistry and Properties
3.2K
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
3.2K
Complexation Equilibria: The Chelate Effect
1.1K
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
1.1K


